References
- Fonseca R, Bergsagel PL, Drach J, et al. International Myeloma Working Group molecular classification of MM: spotlight review. Leukemia 2009;23:2210–2221.
- Sawyer JR. The prognostic significance of cytogenetics and molecular profiling in MM. Cancer Genet 2011;204:3–12.
- Sirohi B, Powles R. Multiple myeloma. Lancet 2004;363:875–887.
- Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004;64:1546–1558.
- Smadja NV, Leroux D, Soulier J, et al. Further cytogenetic characterization of MM confirms that 14q32 translocations are a very rare event in hyperdiploid cases. Genes Chromosomes Cancer 2003;38:234–239.
- Chiecchio L, Protheore RKM, Ibrahim AH, et al. Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in MM. Leukemia 2006;20:1610–1617.
- Zhan F, Sawyer I, Tricot G. The role of cytogenetics in myeloma. Leukemia 2006;20:1484–1486.
- Hemato-oncology best practice guidelines [Internet]. British Society for Human Genetics, Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham. Available from: www.cytogenetics.org.uk
- Yi AK, Chang M, Peckham DW, et al. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998;160:5898–5906.
- Decker T, Schneller F, Kronschnabl M, et al. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells:Costimulation with IL-2 results in a highly immunogenic phenotype. Exp Hematol 2000;28:558–568.
- Klein B, Lu ZY, Costes V, et al. Interleukin-10 and Gp130 cytokines in human multiple myeloma. Leuk Lymphoma 1999;34:63–70.
- Oliveira F, de Oliveira L, Leite-Cueva S, et al. Immunostimulatory oligonucleotide metaphase induction in patients with multiple myeloma: a new approach for G-banding analysis. Haematologica 2010;95(Suppl. 2): Abstract 0338.
- Shaffer LG, Slovak ML, Campbell LJ. ISCN: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2009.
- Put N, Konings P, Rack K, et al. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: a Belgian multicentric study. Genes Chromosomes Cancer 2009;48:843–853.